Mesenchymal stem cells and kidney repair

Area of Science:

• Regenerative Medicine
• Nephrology
• Stem Cell Biology

Background:

• Acute renal failure (ARF), now termed acute kidney injury (AKI), presents a significant public health challenge with high mortality rates.
• Current supportive therapies for AKI have limited impact on patient outcomes, highlighting the need for innovative treatments.
• The kidney's regenerative capacity is limited, necessitating novel approaches to repair acute damage.

Purpose of the Study:

• To review the mechanisms of mesenchymal stem cell (MSC) therapy in preclinical models of ARF.
• To explore how MSCs promote kidney regeneration via cell-to-cell communication and paracrine effects.
• To identify key receptors involved in MSC homing, engraftment, and survival in injured kidney tissue.

Main Methods:

• Analysis of preclinical studies investigating MSC-based therapy for ARF.
• Examination of cell-to-cell communication pathways, including soluble factors and extracellular vesicles (microvesicles/exosomes) released by MSCs.
• Identification and elucidation of specific receptors mediating MSC interaction with damaged renal tissue.

Main Results:

• MSCs exhibit tropism for damaged kidney tissue and exert therapeutic effects through paracrine signaling.
• Soluble factors and microvesicles/exosomes released by MSCs play a crucial role in initiating regenerative processes.
• Specific receptors facilitate MSC homing, engraftment, and survival at injury sites, contributing to kidney repair.

Conclusions:

• MSC therapy offers a promising strategy for repairing acutely damaged kidneys, primarily through paracrine mechanisms.
• Understanding MSC-mediated cell communication and homing receptors is key to optimizing regenerative potential.
• While preclinical data are encouraging, further clinical studies, including ongoing phase I trials, are essential to validate MSC therapy's efficacy in human ARF.